These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3109778)

  • 1. Stability of free apolipoprotein A-1 concentration in serum, and its measurement in normal and hyperlipidemic subjects.
    Neary RH; Gowland E
    Clin Chem; 1987 Jul; 33(7):1163-9. PubMed ID: 3109778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the phenotyping system of hyperlipoproteinemias. Evaluation of a new method by enzymic staining of lipids in serum lipoproteins separated by electrophoresis on agarose.
    Ohno F; Suehiro T; Uga S; Kawada M; Takamatsu K; Yasuoka N; Yamano T
    Jpn J Med; 1983 Aug; 22(3):200-5. PubMed ID: 6620708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia.
    Schonfeld G; George PK; Miller J; Reilly P; Witztum J
    Metabolism; 1979 Oct; 28(10):1001-10. PubMed ID: 226830
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia.
    Holmquist L
    Acta Med Scand; 1984; 215(2):113-20. PubMed ID: 6702490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia.
    Luc G; de Gennes JL; Chapman MJ
    Atherosclerosis; 1988 Jun; 71(2-3):143-56. PubMed ID: 3401287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of the immunoenzyme technic in double determination of antibodies for the study of hyperlipoproteinemia].
    Kandoussi A; Cachera C; Reade R; Tacquet A; Fruchart JC
    Ann Biol Clin (Paris); 1990; 48(6):365-8. PubMed ID: 2221495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and effect of apo A-IV genotype on plasma lipid and apolipoprotein levels in a Chinese population.
    Bai H; Liu R; Liu Y; Saku K; Liu BW
    Acta Cardiol; 2008 Jun; 63(3):315-22. PubMed ID: 18664021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HDL, HDL2 and HDL3 cholesterol in various types of hyperlipoproteinemia in relation to clinical signs of arteriosclerosis].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1986; 29(3):194-203. PubMed ID: 3773408
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns.
    Franceschini G; Sirtori CR; Bosisio E; Gualandri V; Orsini GB; Mogavero AM; Capurso A
    Atherosclerosis; 1985 Dec; 58(1-3):159-74. PubMed ID: 3937534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of high density lipoprotein cholesterol and apoliproprotein A-I concentrations by a lipid-lowering diet.
    Vessby B; Boberg J; Gustafsson IB; Karlström B; Lithell H; Ostlund-Linqvist AM
    Atherosclerosis; 1980 Jan; 35(1):21-7. PubMed ID: 6768372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
    Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunochemical determination of apolipoprotein A, total apolipoprotein A-I and 'free' apolipoprotein A-I in serum of patients on chronic haemodialysis.
    Gebhardt DO; Schicht IM; Paul LC
    Ann Clin Biochem; 1984 Jul; 21 ( Pt 4)():301-5. PubMed ID: 6435499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system.
    Koizumi J; Inazu A; Fujita H; Takeda M; Uno Y; Kajinami K; Mabuchi H; Takeda R
    Atherosclerosis; 1988 Nov; 74(1-2):1-8. PubMed ID: 3145747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.